The global market for Atropine Sulfate API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Atropine Sulfate API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine Sulfate API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Atropine Sulfate API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Atropine Sulfate API include Ss Pharma, Mylan Laboratories Ltd, Alchem International Private Ltd, C-Squared Pharma Sarl, Resonance Laboratories Pvt Ltd, Saurav Chemicals Ltd, Rolabo Outsourcing Sl, Curia Wisconsin Inc and Hubei Biocause Heilen Pharmaceutical Co Ltd, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atropine Sulfate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atropine Sulfate API by region & country, by Type, and by Application.
The Atropine Sulfate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine Sulfate API.
Market Segmentation
By Company
Ss Pharma
Mylan Laboratories Ltd
Alchem International Private Ltd
C-Squared Pharma Sarl
Resonance Laboratories Pvt Ltd
Saurav Chemicals Ltd
Rolabo Outsourcing Sl
Curia Wisconsin Inc
Hubei Biocause Heilen Pharmaceutical Co Ltd
Sichuan Ren An Pharmaceutical
Minsheng Group Shaoxing Pharmaceutical Co Ltd
Henan Purui Pharmaceutical Co Ltd
Guangzhou Hanfang Pharmaceutical Company
China Resources Double-Crane Pharmaceutical
Changzhou Kangpu Pharmaceutical
Segment by Type:
±Ê³Ü°ù¾±³Ù²â≥99%
Purity<99%
Segment by Application
Solution
Eye Drops
Tablet
Injection
Aerosol
Capsule
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Atropine Sulfate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Atropine Sulfate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Atropine Sulfate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Atropine Sulfate API Product Introduction
1.2 Global Atropine Sulfate API Market Size Forecast
1.2.1 Global Atropine Sulfate API Sales Value (2019-2030)
1.2.2 Global Atropine Sulfate API Sales Volume (2019-2030)
1.2.3 Global Atropine Sulfate API Sales Price (2019-2030)
1.3 Atropine Sulfate API Market Trends & Drivers
1.3.1 Atropine Sulfate API Industry Trends
1.3.2 Atropine Sulfate API Market Drivers & Opportunity
1.3.3 Atropine Sulfate API Market Challenges
1.3.4 Atropine Sulfate API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Atropine Sulfate API Players Revenue Ranking (2023)
2.2 Global Atropine Sulfate API Revenue by Company (2019-2024)
2.3 Global Atropine Sulfate API Players Sales Volume Ranking (2023)
2.4 Global Atropine Sulfate API Sales Volume by Company Players (2019-2024)
2.5 Global Atropine Sulfate API Average Price by Company (2019-2024)
2.6 Key Manufacturers Atropine Sulfate API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Atropine Sulfate API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Atropine Sulfate API
2.9 Atropine Sulfate API Market Competitive Analysis
2.9.1 Atropine Sulfate API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Atropine Sulfate API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atropine Sulfate API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ±Ê³Ü°ù¾±³Ù²â≥99%
3.1.2 Purity<99%
3.2 Global Atropine Sulfate API Sales Value by Type
3.2.1 Global Atropine Sulfate API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Atropine Sulfate API Sales Value, by Type (2019-2030)
3.2.3 Global Atropine Sulfate API Sales Value, by Type (%) (2019-2030)
3.3 Global Atropine Sulfate API Sales Volume by Type
3.3.1 Global Atropine Sulfate API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Atropine Sulfate API Sales Volume, by Type (2019-2030)
3.3.3 Global Atropine Sulfate API Sales Volume, by Type (%) (2019-2030)
3.4 Global Atropine Sulfate API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Solution
4.1.2 Eye Drops
4.1.3 Tablet
4.1.4 Injection
4.1.5 Aerosol
4.1.6 Capsule
4.2 Global Atropine Sulfate API Sales Value by Application
4.2.1 Global Atropine Sulfate API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Atropine Sulfate API Sales Value, by Application (2019-2030)
4.2.3 Global Atropine Sulfate API Sales Value, by Application (%) (2019-2030)
4.3 Global Atropine Sulfate API Sales Volume by Application
4.3.1 Global Atropine Sulfate API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Atropine Sulfate API Sales Volume, by Application (2019-2030)
4.3.3 Global Atropine Sulfate API Sales Volume, by Application (%) (2019-2030)
4.4 Global Atropine Sulfate API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Atropine Sulfate API Sales Value by Region
5.1.1 Global Atropine Sulfate API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Atropine Sulfate API Sales Value by Region (2019-2024)
5.1.3 Global Atropine Sulfate API Sales Value by Region (2025-2030)
5.1.4 Global Atropine Sulfate API Sales Value by Region (%), (2019-2030)
5.2 Global Atropine Sulfate API Sales Volume by Region
5.2.1 Global Atropine Sulfate API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Atropine Sulfate API Sales Volume by Region (2019-2024)
5.2.3 Global Atropine Sulfate API Sales Volume by Region (2025-2030)
5.2.4 Global Atropine Sulfate API Sales Volume by Region (%), (2019-2030)
5.3 Global Atropine Sulfate API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Atropine Sulfate API Sales Value, 2019-2030
5.4.2 North America Atropine Sulfate API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Atropine Sulfate API Sales Value, 2019-2030
5.5.2 Europe Atropine Sulfate API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Atropine Sulfate API Sales Value, 2019-2030
5.6.2 Asia Pacific Atropine Sulfate API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Atropine Sulfate API Sales Value, 2019-2030
5.7.2 South America Atropine Sulfate API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Atropine Sulfate API Sales Value, 2019-2030
5.8.2 Middle East & Africa Atropine Sulfate API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Atropine Sulfate API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Atropine Sulfate API Sales Value
6.2.1 Key Countries/Regions Atropine Sulfate API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Atropine Sulfate API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Atropine Sulfate API Sales Value, 2019-2030
6.3.2 United States Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Atropine Sulfate API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Atropine Sulfate API Sales Value, 2019-2030
6.4.2 Europe Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Atropine Sulfate API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Atropine Sulfate API Sales Value, 2019-2030
6.5.2 China Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Atropine Sulfate API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Atropine Sulfate API Sales Value, 2019-2030
6.6.2 Japan Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Atropine Sulfate API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Atropine Sulfate API Sales Value, 2019-2030
6.7.2 South Korea Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Atropine Sulfate API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Atropine Sulfate API Sales Value, 2019-2030
6.8.2 Southeast Asia Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Atropine Sulfate API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Atropine Sulfate API Sales Value, 2019-2030
6.9.2 India Atropine Sulfate API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Atropine Sulfate API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ss Pharma
7.1.1 Ss Pharma Company Information
7.1.2 Ss Pharma Introduction and Business Overview
7.1.3 Ss Pharma Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ss Pharma Atropine Sulfate API Product Offerings
7.1.5 Ss Pharma Recent Development
7.2 Mylan Laboratories Ltd
7.2.1 Mylan Laboratories Ltd Company Information
7.2.2 Mylan Laboratories Ltd Introduction and Business Overview
7.2.3 Mylan Laboratories Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Mylan Laboratories Ltd Atropine Sulfate API Product Offerings
7.2.5 Mylan Laboratories Ltd Recent Development
7.3 Alchem International Private Ltd
7.3.1 Alchem International Private Ltd Company Information
7.3.2 Alchem International Private Ltd Introduction and Business Overview
7.3.3 Alchem International Private Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Alchem International Private Ltd Atropine Sulfate API Product Offerings
7.3.5 Alchem International Private Ltd Recent Development
7.4 C-Squared Pharma Sarl
7.4.1 C-Squared Pharma Sarl Company Information
7.4.2 C-Squared Pharma Sarl Introduction and Business Overview
7.4.3 C-Squared Pharma Sarl Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 C-Squared Pharma Sarl Atropine Sulfate API Product Offerings
7.4.5 C-Squared Pharma Sarl Recent Development
7.5 Resonance Laboratories Pvt Ltd
7.5.1 Resonance Laboratories Pvt Ltd Company Information
7.5.2 Resonance Laboratories Pvt Ltd Introduction and Business Overview
7.5.3 Resonance Laboratories Pvt Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Resonance Laboratories Pvt Ltd Atropine Sulfate API Product Offerings
7.5.5 Resonance Laboratories Pvt Ltd Recent Development
7.6 Saurav Chemicals Ltd
7.6.1 Saurav Chemicals Ltd Company Information
7.6.2 Saurav Chemicals Ltd Introduction and Business Overview
7.6.3 Saurav Chemicals Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Saurav Chemicals Ltd Atropine Sulfate API Product Offerings
7.6.5 Saurav Chemicals Ltd Recent Development
7.7 Rolabo Outsourcing Sl
7.7.1 Rolabo Outsourcing Sl Company Information
7.7.2 Rolabo Outsourcing Sl Introduction and Business Overview
7.7.3 Rolabo Outsourcing Sl Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Rolabo Outsourcing Sl Atropine Sulfate API Product Offerings
7.7.5 Rolabo Outsourcing Sl Recent Development
7.8 Curia Wisconsin Inc
7.8.1 Curia Wisconsin Inc Company Information
7.8.2 Curia Wisconsin Inc Introduction and Business Overview
7.8.3 Curia Wisconsin Inc Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Curia Wisconsin Inc Atropine Sulfate API Product Offerings
7.8.5 Curia Wisconsin Inc Recent Development
7.9 Hubei Biocause Heilen Pharmaceutical Co Ltd
7.9.1 Hubei Biocause Heilen Pharmaceutical Co Ltd Company Information
7.9.2 Hubei Biocause Heilen Pharmaceutical Co Ltd Introduction and Business Overview
7.9.3 Hubei Biocause Heilen Pharmaceutical Co Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hubei Biocause Heilen Pharmaceutical Co Ltd Atropine Sulfate API Product Offerings
7.9.5 Hubei Biocause Heilen Pharmaceutical Co Ltd Recent Development
7.10 Sichuan Ren An Pharmaceutical
7.10.1 Sichuan Ren An Pharmaceutical Company Information
7.10.2 Sichuan Ren An Pharmaceutical Introduction and Business Overview
7.10.3 Sichuan Ren An Pharmaceutical Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sichuan Ren An Pharmaceutical Atropine Sulfate API Product Offerings
7.10.5 Sichuan Ren An Pharmaceutical Recent Development
7.11 Minsheng Group Shaoxing Pharmaceutical Co Ltd
7.11.1 Minsheng Group Shaoxing Pharmaceutical Co Ltd Company Information
7.11.2 Minsheng Group Shaoxing Pharmaceutical Co Ltd Introduction and Business Overview
7.11.3 Minsheng Group Shaoxing Pharmaceutical Co Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Minsheng Group Shaoxing Pharmaceutical Co Ltd Atropine Sulfate API Product Offerings
7.11.5 Minsheng Group Shaoxing Pharmaceutical Co Ltd Recent Development
7.12 Henan Purui Pharmaceutical Co Ltd
7.12.1 Henan Purui Pharmaceutical Co Ltd Company Information
7.12.2 Henan Purui Pharmaceutical Co Ltd Introduction and Business Overview
7.12.3 Henan Purui Pharmaceutical Co Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Henan Purui Pharmaceutical Co Ltd Atropine Sulfate API Product Offerings
7.12.5 Henan Purui Pharmaceutical Co Ltd Recent Development
7.13 Guangzhou Hanfang Pharmaceutical Company
7.13.1 Guangzhou Hanfang Pharmaceutical Company Company Information
7.13.2 Guangzhou Hanfang Pharmaceutical Company Introduction and Business Overview
7.13.3 Guangzhou Hanfang Pharmaceutical Company Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Guangzhou Hanfang Pharmaceutical Company Atropine Sulfate API Product Offerings
7.13.5 Guangzhou Hanfang Pharmaceutical Company Recent Development
7.14 China Resources Double-Crane Pharmaceutical
7.14.1 China Resources Double-Crane Pharmaceutical Company Information
7.14.2 China Resources Double-Crane Pharmaceutical Introduction and Business Overview
7.14.3 China Resources Double-Crane Pharmaceutical Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.14.4 China Resources Double-Crane Pharmaceutical Atropine Sulfate API Product Offerings
7.14.5 China Resources Double-Crane Pharmaceutical Recent Development
7.15 Changzhou Kangpu Pharmaceutical
7.15.1 Changzhou Kangpu Pharmaceutical Company Information
7.15.2 Changzhou Kangpu Pharmaceutical Introduction and Business Overview
7.15.3 Changzhou Kangpu Pharmaceutical Atropine Sulfate API Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Changzhou Kangpu Pharmaceutical Atropine Sulfate API Product Offerings
7.15.5 Changzhou Kangpu Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Atropine Sulfate API Industrial Chain
8.2 Atropine Sulfate API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Atropine Sulfate API Sales Model
8.5.2 Sales Channel
8.5.3 Atropine Sulfate API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Ss Pharma
Mylan Laboratories Ltd
Alchem International Private Ltd
C-Squared Pharma Sarl
Resonance Laboratories Pvt Ltd
Saurav Chemicals Ltd
Rolabo Outsourcing Sl
Curia Wisconsin Inc
Hubei Biocause Heilen Pharmaceutical Co Ltd
Sichuan Ren An Pharmaceutical
Minsheng Group Shaoxing Pharmaceutical Co Ltd
Henan Purui Pharmaceutical Co Ltd
Guangzhou Hanfang Pharmaceutical Company
China Resources Double-Crane Pharmaceutical
Changzhou Kangpu Pharmaceutical
Ìý
Ìý
*If Applicable.
